India to Kenya: Regorafenib Export Trade Route
India has recorded 34 verified shipments of Regorafenib exported to Kenya, representing a combined trade value of $36.1K USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $1.1K USD. The leading Indian exporter is R.S. SURGIPHARM PRIVATE LIMITED, which accounts for 33% of total export value with 9 shipments worth $12.0K USD. On the buying side, TO is the largest importer in Kenya with $12.4K USD in purchases. The top 3 suppliers — R.S. SURGIPHARM PRIVATE LIMITED, 3S CORPORATION, SINI PHARMA PRIVATE LIMITED — together control 73% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Regorafenib corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $36.1K USD. The route is dominated by R.S. SURGIPHARM PRIVATE LIMITED, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $1.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with regorafenib's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 29.8%, placing it at rank #20 among India's top regorafenib export destinations globally.
On the import side, key buyers of Indian regorafenib in Kenya include TO, TO THE ORDER OF, FOR THE ORDER OF and 14 others. TO is the single largest importer with 10 shipments valued at $12.4K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#20
- Annual growth+29.8%
- Demand growth+25.0%
- Regulatory ease77/100
Top 10 Indian Regorafenib Exporters to Kenya
Showing top 10 of 12 Indian suppliers exporting Regorafenib to Kenya, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | R.S. SURGIPHARM PRIVATE LIMITED Avg $1.3K per shipment | 9 | $12.0K | 33.3% |
| 2 | 3S CORPORATION Avg $1.6K per shipment | 6 | $9.4K | 25.9% |
| 3 | SINI PHARMA PRIVATE LIMITED Avg $1.2K per shipment | 4 | $4.9K | 13.5% |
| 4 | ASPIRA BIOHEALTH LLP Avg $2.2K per shipment | 1 | $2.2K | 6.1% |
| 5 | R S SURGIPHARM PRIVATE LIMITED Avg $703 per shipment | 3 | $2.1K | 5.8% |
| 6 | ASPIDA LIFE SCIENCES PRIVATE LIMITED Avg $946 per shipment | 2 | $1.9K | 5.2% |
| 7 | 3S CORPORATION Avg $984 per shipment | 1 | $984 | 2.7% |
| 8 | PLASMA LIFE CARE Avg $458 per shipment | 2 | $916 | 2.5% |
| 9 | ASPIRA BIOHEALTH LLP Avg $350 per shipment | 2 | $701 | 1.9% |
| 10 | R.S. SURGIPHARM PRIVATE LIMITED Avg $247 per shipment | 2 | $493 | 1.4% |
This table shows the top 10 of 12 Indian companies exporting regorafenib to Kenya, ranked by total trade value. The listed exporters are: R.S. SURGIPHARM PRIVATE LIMITED, 3S CORPORATION, SINI PHARMA PRIVATE LIMITED, ASPIRA BIOHEALTH LLP , R S SURGIPHARM PRIVATE LIMITED, ASPIDA LIFE SCIENCES PRIVATE LIMITED, 3S CORPORATION , PLASMA LIFE CARE, ASPIRA BIOHEALTH LLP, R.S. SURGIPHARM PRIVATE LIMITED . R.S. SURGIPHARM PRIVATE LIMITED is the dominant supplier with 9 shipments worth $12.0K USD, giving it a 33% market share. The top 3 suppliers together account for 73% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to Kenya Regorafenib export route.
Top 10 Regorafenib Importers in Kenya
Showing top 10 of 17 known buyers in Kenya receiving Regorafenib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian regorafenib in Kenya include TO, TO THE ORDER OF, FOR THE ORDER OF, NA, FOR THE ORDER OF RAKAGIY GROUP LIMITED, among 17 total buyers. The largest importer is TO, accounting for $12.4K USD across 10 shipments — representing 34% of all regorafenib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO | 10 | $12.4K | 34.4% |
| 2 | TO THE ORDER OF | 3 | $4.4K | 12.1% |
| 3 | FOR THE ORDER OF | 2 | $3.8K | 10.4% |
| 4 | NA | 1 | $2.8K | 7.8% |
| 5 | FOR THE ORDER OF RAKAGIY GROUP LIMITED | 3 | $2.8K | 7.7% |
| 6 | INSPIRE PHARMACEUTICALS LTD | 1 | $2.2K | 6.1% |
| 7 | TO THE ORDER OF INVOICE RAISED TO: | 2 | $1.9K | 5.2% |
| 8 | TO THE ORDER | 2 | $1.7K | 4.8% |
| 9 | FOR THE ORDER OF , . | 1 | $984 | 2.7% |
| 10 | MEDSERV AFRICA LIMITED | 1 | $550 | 1.5% |
Showing top 10 of 17 Regorafenib importers in Kenya on this route.
Top 10 Regorafenib Formulations Imported by Kenya
Showing top 10 of 28 product formulations shipped on the India to Kenya Regorafenib route, ranked by trade value
Kenya imports a wide range of regorafenib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS DRUGS AND PHARMACEUTICAL FINISHED PRODUCT FOR HUMAN USE: REGORAFENIB 40MG (REGONAT)NOS — accounts for $3.1K USD across 1 shipments. There are 28 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS DRUGS AND PHARMACEUTICAL FINISHED PRODUCT FOR HUMAN USE: REGORAFENIB 40MG (REGONAT)NOS | 1 | $3.1K | 8.5% |
| 2 | Regorafenib Tab 40 Mg | 1 | $2.8K | 7.8% |
| 3 | (HARMLESS MEDICINES INJECATABLE AND TABLETS) REGORAFENIB TABLETS 40MG (1X28) | 2 | $2.8K | 7.8% |
| 4 | REGORAFENIB TAB 40 MG TOTAL QTY 10 PACK | 3 | $2.8K | 7.7% |
| 5 | (HARMLESS MEDICINES INJECATABLE AND TABLETS) REGORAFENIB TABLETS 40MG | 1 | $2.8K | 7.7% |
| 6 | (HARMLESS MEDICINES INJECATABLE AND TABLETS)REGORAFENIB TABLETS 40MG 1X28 | 1 | $2.3K | 6.4% |
| 7 | REGORAFENIB TABLETS 40MG BRAND : REGONAT | 1 | $2.2K | 6.1% |
| 8 | REGORAFENIB TAB 40 MGNOS | 1 | $2.0K | 5.7% |
| 9 | HARMLESS MEDI. FOR HUMAN REGORAFENIB TABLETS BP 40 MG 1*28 TABLETS BATCH NO .: T25RE01A1 | 2 | $1.9K | 5.2% |
| 10 | REGORAFENIB 40MG TAB (1X28) | 3 | $1.8K | 5.1% |
Showing top 10 of 28 Regorafenib formulations imported by Kenya on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 18 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's regorafenib exports to Kenya are driven primarily by a handful of large-scale manufacturers. R.S. SURGIPHARM PRIVATE LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — R.S. SURGIPHARM PRIVATE LIMITED, 3S CORPORATION, SINI PHARMA PRIVATE LIMITED — together account for 73% of total trade value on this route. The average shipment value of $1.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as regorafenib tab 40 mg and (harmless medicines injecatable and tablets) regorafenib tablets 40mg (1x28), suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO is the largest importer with 10 shipments worth $12.4K USD — representing 34% of all regorafenib imports from India on this route. A total of 17 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $36.1K
- Avg. Shipment
- $1.1K
- Suppliers
- 12
- Buyers
- 17
- Transit (Sea)
- ~15 days
- Annual Growth
- +29.8%
Related Analysis
Other Regorafenib Routes
Unlock the Full India to Kenya Regorafenib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 34 shipments on this route.
Frequently Asked Questions — India to Kenya Regorafenib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Regorafenib to Kenya?
The leading Indian exporters of Regorafenib to Kenya are R.S. SURGIPHARM PRIVATE LIMITED, 3S CORPORATION, SINI PHARMA PRIVATE LIMITED. R.S. SURGIPHARM PRIVATE LIMITED holds the largest market share at approximately 33% of total trade value on this route.
Q What is the total value of Regorafenib exports from India to Kenya?
India exports Regorafenib to Kenya worth approximately $36.1K USD across 34 recorded shipments. The average value per shipment is $1.1K USD.
Q Which ports does India use to ship Regorafenib to Kenya?
The most active port of origin is SAHAR AIR with 18 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Kenya for Regorafenib?
The average transit time for Regorafenib shipments from India to Kenya is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Kenya Regorafenib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.8% with demand growth tracking at 25.0%. The route is ranked #20 among India's top Regorafenib export destinations globally.
Q How many suppliers are active on the India to Kenya Regorafenib route?
There are currently 12 active Indian suppliers exporting Regorafenib to Kenya. The market is moderately concentrated with R.S. SURGIPHARM PRIVATE LIMITED accounting for 33% of total shipment value.
Q Who are the main importers of Regorafenib from India in Kenya?
The leading importers of Indian Regorafenib in Kenya include TO, TO THE ORDER OF, FOR THE ORDER OF, NA, FOR THE ORDER OF RAKAGIY GROUP LIMITED. TO is the largest buyer with 10 shipments worth $12.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Kenya export trade corridor identified from Indian Customs (DGFT) records for Regorafenib.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 17 importers in Kenya matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 34 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
34 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists